investing

IQVIA Vertex Pharmaceuticals Danaher

Analysts highlight IQVIA (IQV) and Danaher (DHR) as leading biotech stocks poised for recovery

The biotechnology sector, which has faced significant challenges in recent years, is showing signs of recovery, presenting potential investment opportunities in companies like IQVIA, Danaher, and Vertex Pharmaceuticals. This shift is driven by stabilizing funding conditions, increased clinical trial activity, and the need for pharmaceutical companies to innovate as patent expirations loom.
T-Mobile US Netflix

Analysts HSBC raise earnings estimates for Netflix (NFLX) and T-Mobile (TMUS) despite declining share prices

Wall Street analysts are increasing earnings estimates for several stocks despite recent declines in their share prices, indicating potentially attractive valuations as the second-quarter earnings season approaches. This trend highlights opportunities in sectors with strong earnings visibility, particularly in energy and technology.